Balasa Dinverno & Foltz’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,445
| Closed | -$243K | – | 283 |
|
|
2019
Q3 | $243K | Hold |
2,445
| – | – | 0.03% | 218 |
|
|
2019
Q2 | $226K | Sell |
2,445
-57
| -2% | -$5.27K | 0.03% | 224 |
|
|
2019
Q1 | $236K | Buy |
+2,502
| New | +$236K | 0.03% | 217 |
|
|
2018
Q4 | – | Sell |
-3,714
| Closed | -$332K | – | 258 |
|
|
2018
Q3 | $332K | Buy |
3,714
+81
| +2% | +$7.24K | 0.04% | 181 |
|
|
2018
Q2 | $289K | Buy |
3,633
+241
| +7% | +$19.2K | 0.04% | 178 |
|
|
2018
Q1 | $303K | Sell |
3,392
-572
| -14% | -$51.1K | 0.05% | 165 |
|
|
2017
Q4 | $414K | Sell |
3,964
-165
| -4% | -$17.2K | 0.06% | 135 |
|
|
2017
Q3 | $602K | Buy |
4,129
+40
| +1% | +$5.83K | 0.09% | 98 |
|
|
2017
Q2 | $531K | Buy |
4,089
+91
| +2% | +$11.8K | 0.09% | 111 |
|
|
2017
Q1 | $497K | Sell |
3,998
-258
| -6% | -$32.1K | 0.08% | 103 |
|
|
2016
Q4 | $493K | Buy |
4,256
+494
| +13% | +$57.2K | 0.08% | 95 |
|
|
2016
Q3 | $393K | Sell |
3,762
-162
| -4% | -$16.9K | 0.07% | 115 |
|
|
2016
Q2 | $387K | Sell |
3,924
-220
| -5% | -$21.7K | 0.07% | 113 |
|
|
2016
Q1 | $415K | Sell |
4,144
-215
| -5% | -$21.5K | 0.07% | 103 |
|
|
2015
Q4 | $522K | Sell |
4,359
-439
| -9% | -$52.6K | 0.09% | 92 |
|
|
2015
Q3 | $519K | Buy |
4,798
+36
| +0.8% | +$3.89K | 0.09% | 87 |
|
|
2015
Q2 | $551K | Buy |
4,762
+75
| +2% | +$8.68K | 0.09% | 79 |
|
|
2015
Q1 | $540K | Sell |
4,687
-613
| -12% | -$70.6K | 0.08% | 78 |
|
|
2014
Q4 | $593K | Sell |
5,300
-20
| -0.4% | -$2.24K | 0.09% | 78 |
|
|
2014
Q3 | $504K | Buy |
5,320
+20
| +0.4% | +$1.9K | 0.08% | 84 |
|
|
2014
Q2 | $455K | Buy |
5,300
+1,140
| +27% | +$97.9K | 0.05% | 89 |
|
|
2014
Q1 | $290K | Buy |
4,160
+438
| +12% | +$30.5K | 0.04% | 124 |
|
|
2013
Q4 | $314K | Buy |
3,722
+20
| +0.5% | +$1.69K | 0.04% | 105 |
|
|
2013
Q3 | $285K | Buy |
3,702
+82
| +2% | +$6.31K | 0.05% | 103 |
|
|
2013
Q2 | $212K | Buy |
+3,620
| New | +$212K | 0.04% | 124 |
|